Pleotropic effects of a recessive COL1A2 mutation occurring in a mouse model of severe osteogenesis imperfecta (2024)

First Author: Corcelli M

Attributed to: Combining iPSC and gene editing with cell therapy to develop the next generation of MSC-based therapeutics to counteract bone fragility in OI. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2024.02.15.580510

Publication URI: http://dx.doi.org/10.1101/2024.02.15.580510

Type: Preprint